awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q48059175-8079E36F-9DE7-4FDA-A53B-DBE7EACAD668
Q48059175-8079E36F-9DE7-4FDA-A53B-DBE7EACAD668
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48059175-8079E36F-9DE7-4FDA-A53B-DBE7EACAD668
Tofacitinib withdrawal and retreatment in moderate-to-severe chronic plaque psoriasis: a randomized controlled trial.
P2860
Q48059175-8079E36F-9DE7-4FDA-A53B-DBE7EACAD668
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48059175-8079E36F-9DE7-4FDA-A53B-DBE7EACAD668
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
220863bc49280042ebffcff784f400a583ecc362
P2860
Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)